- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
News 39 results
Recognition
November 10, 2021
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Seventh Year
In the News · Source: Capital & Main
November 8, 2021
Dixie Johnson, Amanda Sonneborn and Keith Townsend’s client alert that examined the SEC enforcement of human capital disclosures is referenced
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
September 1, 2021
Benchmark Names Three King & Spalding Partners to List of Top 250 Women in Litigation
Events 17 results
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Speaking Engagement
January 25, 2021
Dixie Johnson, Richard Walker to Speak on 2021 Securities Regulation Institute’s Virtual Conference
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
November 6, 2020
Dixie Johnson, Richard Walker to Speak on Live Webcast of PLI’s 52nd Annual Institute on Securities Regulations
Insights 34 results
Client Alert
September 28, 2021
SEC Enforcement of Human Capital Disclosures: The First Fingerprints
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Technology Industry